Cardlytics, Inc. (NASDAQ:CDLX) Given Average Rating of “Hold” by Brokerages

Cardlytics, Inc. (NASDAQ:CDLX) has been assigned an average recommendation of “Hold” from the seven analysts that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a strong buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $6.42.

Several analysts recently weighed in on the company. Evercore ISI decreased their price target on Cardlytics from $4.00 to $3.00 and set an “in-line” rating on the stock in a report on Thursday, March 13th. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a report on Thursday, March 13th. Finally, Lake Street Capital decreased their price objective on shares of Cardlytics from $5.00 to $3.00 and set a “hold” rating for the company in a research note on Thursday, March 13th.

Insider Buying and Selling

In related news, CEO Amit Gupta sold 46,857 shares of Cardlytics stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total transaction of $159,313.80. Following the completion of the sale, the chief executive officer now owns 418,637 shares of the company’s stock, valued at $1,423,365.80. The trade was a 10.07 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Alexis Desieno sold 24,778 shares of the stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total transaction of $84,245.20. Following the completion of the sale, the chief financial officer now owns 140,948 shares in the company, valued at $479,223.20. The trade was a 14.95 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 111,454 shares of company stock valued at $391,864 over the last three months. 4.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On Cardlytics

Large investors have recently bought and sold shares of the business. Tallon Kerry Patrick purchased a new position in shares of Cardlytics in the fourth quarter valued at approximately $37,000. Atom Investors LP acquired a new stake in Cardlytics during the third quarter worth $33,000. ProShare Advisors LLC purchased a new position in shares of Cardlytics during the fourth quarter worth $43,000. Intech Investment Management LLC acquired a new position in shares of Cardlytics in the third quarter worth $47,000. Finally, Virtu Financial LLC purchased a new stake in shares of Cardlytics during the fourth quarter worth approximately $62,000. Institutional investors and hedge funds own 68.10% of the company’s stock.

Cardlytics Stock Performance

Shares of NASDAQ:CDLX opened at $2.15 on Friday. The stock has a market capitalization of $111.98 million, a P/E ratio of -0.35 and a beta of 1.62. Cardlytics has a 52 week low of $1.77 and a 52 week high of $16.31. The firm has a fifty day simple moving average of $2.87 and a two-hundred day simple moving average of $3.42. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.